| Literature DB >> 35052238 |
Javier Esparza-Reig1, Manuel Martí-Vilar1, César Merino-Soto2, Alfredo García-Casique3.
Abstract
The relationship of addiction problems with other pathologies or with different problematic factors has often been studied by psychology. Positive psychology is also currently approaching to these problems and their relationship with positive factors, such as prosocial behaviours. The purpose of this research is to carry out a systematic review of the scientific literature that has studied this relationship from 1900 to 2020. After the screening process with the inclusion and exclusion criteria, a total of 15 articles were selected. The main characteristics found in this relationship and the problems or limitations of investigations that have found relationships other than the mainstream, which show a negative relationship between prosocial behaviours and addiction problems, are discussed.Entities:
Keywords: addiction; gambling; positive psychology; prosocial behaviour; substance abuse
Year: 2021 PMID: 35052238 PMCID: PMC8774983 DOI: 10.3390/healthcare10010074
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Figure 1Flowchart of the selection and screening process of the systematic review articles according to the PRISMA method.
Information of the articles selected for the review.
| Authors (Year) and Country | Studied Addiction and Aims | Sample | Design | Method | Results |
|---|---|---|---|---|---|
| Carlo, Crockett, Wilkinson, and Beal (2011); | Tobacco, cannabis and alcohol; | Longitudinal | 5-year longitudinal study; to measure substance use, a 6-point Likert item was applied to collect the consumption of tobacco, alcohol, and marijuana; to measure prosocial behaviours, the Primary Prevention Awareness, Attitudes, and Usage Scale (PPAAUS; Swisher et al., 1984 [ | Prosocial behaviour in adolescence is negatively correlated with the use of tobacco, cannabis, and alcohol | |
| Collins and Freeman (2013); | Video game; | Cross-sectional | To measure the frequency of video-gaming use, the hours per week were asked; to measure pathological video-gaming use, the short version of the Game Addiction Scale (GA; Lemmens, Valkenburg, and Peter, 2009 [ | Prosocial behaviour is not related to video-gaming frequency or pathological video-gaming | |
| Davis et al. (2016); | Alcohol and cannabis; | Cross-sectional | To measure prosocial behaviours, the PTM (Carlo and Randall, 2002) was applied; for dangerous alcohol consumption, the Alcohol Use Disorders Identification Test (AUDIT; Saunders et al., 1993 [ | Public prosocial behaviour is a positive predictor of alcohol consumption (self-oriented for the approval of others, not altruistic); cannabis use is a negative predictor of anonymous prosocial behaviour (altruistic, other-oriented) | |
| Esparza-Reig (2020); | Gambling addiction; | Cross-sectional | To measure gambling addiction problems, the South Oaks Gambling Screen (SOGS; Lesieur and Blume, 1987 [ | Prosocial behaviour is a protective factor against gambling addiction problems | |
| Esparza-Reig, Martí-Vilar, and González-Sala (2021); Spain | Gambling and alcohol addiction; | Cross-sectional | To measure gambling addiction problems, the South Oaks Gambling Screen (SOGS; Lesieur and Blume, 1987 [ | Prosocial behaviour is a protective factor against both gambling addiction problems and problematic alcohol use | |
| Fenzel (2005); | Alcohol; | Cross-sectional | To measure the frequency of binge drinking in the last two weeks, an item was applied, and a series of items of 3 alternatives that measured whether alcohol consumption had caused them different problems; to measure prosocial behaviours, the number of behaviours of this type carried out by the participants was consulted | Prosocial behaviour is a protective factor against the frequency of binge drinking and the problems derived from this behaviour | |
| Groves, Gentile, Tapscott, and Lynch (2015); | Video game; | (Only research study 2) | Cross-sectional | For pathological gambling, 9 dichotomous items from the General Media Habits Questionnaire (GMHQ; Fisher, 1994 [ | There are no differences (they are not correlated) between pathological and non pathological players in prosocial behaviour |
| Guo et al. (2021); China | Internet; | Cross-sectional | To assess prosocial behaviour, the Strengths and Difficulties Questionnaire (Goodman, 1997 [ | Prosocial behaviour reduces the risk of problematic Internet use | |
| Lemmens, Valkenburg, and Gentile (2015); | Video games; | Cross-sectional | To measure Internet Gambling Disorder, a dichotomous scale was used (in two versions, one with 27 items and another one with 9 items); 5 prosocial items of the Strengths and Difficulties Questionnaire (Goodman, 1997 [ | Video-gaming addiction negatively correlates with prosocial behaviour in both samples, and with the different versions of the Internet Gaming Disorder assessment instrument | |
| Cross-sectional | To measure Internet Gambling Disorder, a 6-point Likert-type scale was used (in two versions, one with 27 items and another one with 9 items); 5 prosocial items of the Strengths and Difficulties Questionnaire (Goodman, 1997 [ | ||||
| Moilanen and Lynn (2019); | Substances of abuse; | Cross-sectional | To assess substance use, participants were asked when they last used different substances of abuse; to assess prosocial behaviour, the PPAAUS prosocial behaviour subscale (Swisher et al., 1984 [ | Prosocial behaviour do not correlate with substance abuse | |
| Quigley and Maggi (2014); | Tobacco, alcohol, and cannabis; | Longitudinal | Longitudinal study. Both substance use and prosocial behaviours are measured trough self-reports | Tobacco and alcohol are not related to prosocial behaviour in childhood; Prosocial behaviour during childhood is a positive predictor of cannabis use | |
| Cross-sectional | |||||
| Schnakenberg and Lysaker (2019); | Cannabis; | Group with addiction problems: | Cross-sectional | To measure cannabis use, the ASI (McLellan et al., 1980 [ | Participants who regularly smoke cannabis show less prosocial behaviours than non-smokers |
| Sun et al. (2021); China | Smartphone addiction; | Cross-sectional | To measure prosocial behaviours, items adapted from the Empathic Responding to SARS Scale (Lee-Baggley et al., 2004 [ | They found a negative correlation between prosocial behaviour and screen time | |
| Tomei, Studer, and Gmel (2021); Switzerland | Addiction to gambling, video-gaming, alcohol, cannabis, and nicotine; | Cross-sectional | To assess prosocial behaviours, the Prosociality Scale (Caprara et al., 2005 [ | Participants with problems of addiction to gambling, video-gaming, and alcohol presented less prosocial behaviour than participants without addiction problems. In the case of tobacco and cannabis, no differences were found. This relationship is especially significant in the case of addictive behaviours | |
| Vonmoos et al. (2019); | Cocaine; | Longitudinal | 1-year longitudinal study; cocaine use was measured at first and after one year by blood concentration (19 participants increased use and 19 participants decreased it); prosocial behaviour was measured with the Distribution/Dictator Game (Charness and Rabin, 2002 [ | The group that decreased consumption and control was closer in their scores in prosocial behaviour after one year; those that increased the use of cocaine maintained the distance in the levels of prosocial behaviour with the control group |
PRISMA 2020 checklist.
| Section and Topic | Item # | Checklist Item | Location Where Item Is Reported |
|---|---|---|---|
| TITLE | |||
| Title | 1 | Identify the report as a systematic review. | Page 1 |
| ABSTRACT | |||
| Abstract | 2 | See the PRISMA 2020 for Abstracts checklist. | Page 1 |
| INTRODUCTION | |||
| Rationale | 3 | Describe the rationale for the review in the context of existing knowledge. | Page 2 |
| Objectives | 4 | Provide an explicit statement of the objective(s) or question(s) the review addresses. | Page 2 |
| METHODS | |||
| Eligibility criteria | 5 | Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses. | Page 3 |
| Information sources | 6 | Specify all databases, registers, websites, organisations, reference lists, and other sources searched or consulted to identify studies. Specify the date when each source was last searched or consulted. | Page 3 |
| Search strategy | 7 | Present the full search strategies for all databases, registers, and websites, including any filters and limits used. | Page 3 |
| Selection process | 8 | Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and, if applicable, details of automation tools used in the process. | Page 3 |
| Data collection process | 9 | Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and, if applicable, details of automation tools used in the process. | Page 3 |
| Data items | 10a | List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g., for all measures, time points, analyses), and, if not, the methods used to decide which results to collect. | Page 3 |
| 10b | List and define all other variables for which data were sought (e.g., participant and intervention characteristics, funding sources). Describe any assumptions made about any missing or unclear information. | Page 3 | |
| Study risk of bias assessment | 11 | Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and, if applicable, details of automation tools used in the process. | - |
| Effect measures | 12 | Specify for each outcome the effect measure(s) (e.g., risk ratio, mean difference) used in the synthesis or presentation of results. | NA |
| Synthesis methods | 13a | Describe the processes used to decide which studies were eligible for each synthesis (e.g., tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)). | Page 3 |
| 13b | Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing summary statistics or data conversions. | - | |
| 13c | Describe any methods used to tabulate or visually display results of individual studies and syntheses. | Page 4 | |
| 13d | Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and software package(s) used. | Page 3 | |
| 13e | Describe any methods used to explore possible causes of heterogeneity among study results (e.g., subgroup analysis, meta-regression). | NA | |
| 13f | Describe any sensitivity analyses conducted to assess robustness of the synthesized results. | - | |
| Reporting bias assessment | 14 | Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases). | - |
| Certainty assessment | 15 | Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome. | - |
| RESULTS | |||
| Study selection | 16a | Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram. | Page 4 |
| 16b | Cite studies that might appear to meet the inclusion criteria but which were excluded, and explain why they were excluded. | - | |
| Study characteristics | 17 | Cite each included study and present its characteristics. | Pages 5–10 |
| Risk of bias in studies | 18 | Present assessments of risk of bias for each included study. | - |
| Results of individual studies | 18 | For all outcomes, present for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g., confidence/credible interval), ideally using structured tables or plots. | Pages 5–10 |
| Results of syntheses | 20a | For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies. | Pages 5–10 |
| 20b | Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary estimate and its precision (e.g., confidence/credible interval) and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect. | NA | |
| 20c | Present results of all investigations of possible causes of heterogeneity among study results. | NA | |
| 20d | Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results. | - | |
| Reporting biases | 21 | Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed. | NA |
| Certainty of evidence | 22 | Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed. | - |
| DISCUSSION | |||
| Discussion | 23a | Provide a general interpretation of the results in the context of other evidence. | Page 12 |
| 23b | Discuss any limitations of the evidence included in the review. | Pages 12–13 | |
| 23c | Discuss any limitations of the review processes used. | Pages 12–13 | |
| 23d | Discuss implications of the results for practice, policy, and future research. | Page 13 | |
| OTHER INFORMATION | |||
| Registration and protocol | 24a | Provide registration information for the review, including register name and registration number, or state that the review was not registered. | - |
| 24b | Indicate where the review protocol can be accessed, or state that a protocol was not prepared. | - | |
| 24c | Describe and explain any amendments to information provided at registration or in the protocol. | - | |
| Support | 25 | Describe sources of financial or non-financial support for the review and the role of the funders or sponsors in the review. | Page 34 |
| Competing interests | 26 | Declare any competing interests of review authors. | Page 34 |
| Availability of data, code and other materials | 27 | Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from included studies; data used for all analyses; analytic code; any other materials used in the review. | - |
NA, Not applicable.